Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duriez

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Scientific Reports|June 4, 2021
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacityBeatriz Valle-Argos, Giorgia Chiodin, Dean J Bryant, et al.
Immunity|June 30, 2009
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspasesAlexander U Lüthi, Sean P Cullen, Edel A McNeela, et al.
Blood|January 20, 2026
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and SurvivalGiorgia Chiodin, Dylan James Tatterton, Philip J Rock, et al.
Chemmedchem|February 3, 2021
Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid LeukemiaMaria Teresa Borrello, Hanae Benelkebir, Adam Lee, et al.
Nature Communications|June 29, 2026
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilitiesRosendo C Villafuerte-Vega, Michael R Armbruster, Hayden Fisher, et al.
Blood|January 30, 2015
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodiesThomas R W Tipton, Ali Roghanian, Robert J Oldham, et al.
Nature Communications|April 12, 2025
Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonismIsabel G Elliott, Hayden Fisher, H T Claude Chan, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2018
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical modelAlex Allen, Chuan Wang, Lisa J Caproni, et al.
Blood|September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaDylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Cancer Research|May 18, 2017
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ImmunotherapyLekh N Dahal, Lang Dou, Khiyam Hussain, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Scientific Reports|June 4, 2021
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacityBeatriz Valle-Argos, Giorgia Chiodin, Dean J Bryant, et al.
Immunity|June 30, 2009
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspasesAlexander U Lüthi, Sean P Cullen, Edel A McNeela, et al.
Blood|January 20, 2026
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and SurvivalGiorgia Chiodin, Dylan James Tatterton, Philip J Rock, et al.
Chemmedchem|February 3, 2021
Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid LeukemiaMaria Teresa Borrello, Hanae Benelkebir, Adam Lee, et al.
Nature Communications|June 29, 2026
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilitiesRosendo C Villafuerte-Vega, Michael R Armbruster, Hayden Fisher, et al.
Blood|January 30, 2015
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodiesThomas R W Tipton, Ali Roghanian, Robert J Oldham, et al.
Nature Communications|April 12, 2025
Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonismIsabel G Elliott, Hayden Fisher, H T Claude Chan, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2018
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical modelAlex Allen, Chuan Wang, Lisa J Caproni, et al.
Blood|September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaDylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Cancer Research|May 18, 2017
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ImmunotherapyLekh N Dahal, Lang Dou, Khiyam Hussain, et al.
Pageof 6